4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-015368
Director acquired 4,660 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powell Andrew Kenneth William Director | 2024-06-01 | Option exercise | +4,660 | 33,523 | D | ||
| Derivatives | |||||||
| Powell Andrew Kenneth William Director | 2024-06-01 | Option exercise · Restricted Stock Units | −4,660 | 0 | D | ||
Loading xslF345X05/form4-06042024_040616.xml…